可可
Lv4
570 积分
2024-03-20 加入
-
A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study
20小时前
已完结
-
Association of body mass index with life expectancy with and without cardiovascular disease
26天前
已完结
-
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
26天前
已完结
-
Obesity in adults
26天前
已完结
-
National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050
26天前
已完结
-
Effect of a Lifestyle Intervention on Cardiometabolic Health Among Emerging Adults
26天前
已完结
-
Effectiveness and Safety of the TRIO Optimal Health Management Program in Patients with Type 2 Diabetes Mellitus (T2DM) Initiating Basal Insulin Therapy: Real-World Study (Preprint)
30天前
已完结
-
A biweekly DPP‐4 inhibitor cofrogliptin monotherapy in Chinese patients with impaired glucose tolerance: A phase 2, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial
30天前
已完结
-
Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials
30天前
已完结
-
Real-world safety of dapagliflozin plus metformin in patients of type 2 diabetes mellitus in China: Post-hoc analysis of the DONATE study
30天前
已关闭